Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04217577 · ClinicalTrials.gov registry record · NA
Dried Plum Supplementation as Treatment for Bone Loss Following Spinal Cord Injury
A NA study, sponsored by VA Palo Alto Health Care System.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT04217577: Clinical Trial NA study, sponsored by VA Palo Alto Health Care System.
NCT04217577 is a NA study that was terminated before completion, run by VA Palo Alto Health Care System. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04217577, a NA study, was terminated before completion, sponsored by VA Palo Alto Health Care System.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to explore whether dried plum (prunes) added to the diet is effective in reducing or reversing bone loss following spinal cord injury (SCI). The investigators will look for changes in bone mineral density as well as evidence in the blood of markers of bone activity. The first part of the study is to check whether participants with SCI can and will eat the required amount of dried plums (prunes) on a daily basis. The second part of the study is to follow participants over one year and look for changes in bone mass and blood markers.
Primary Outcome
Blood marker of bone formation
Interventions
- DIETARY_SUPPLEMENT Dried plums
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-01-20 |
| Est. Completion | 2020-03-20 |
| Phase | NA |
Why NCT04217577 stopped before completion
NCT04217577 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Dried plums is the first listed.
NCT04217577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04217577 about?
NCT04217577 is a clinical study titled "Dried Plum Supplementation as Treatment for Bone Loss Following Spinal Cord Injury". The purpose of this pilot study is to explore whether dried plum (prunes) added to the diet is effective in reducing or reversing bone loss following spinal cord injury (SCI). The investigators will look for changes in bone mineral density as well as evidence in the blood of markers of bone activity...
What is the current status of trial NCT04217577?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2019-01-20. Estimated completion is 2020-03-20.
What interventions are being tested in trial NCT04217577?
The interventions under investigation include: Dried plums (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04217577?
This trial is sponsored by VA Palo Alto Health Care System, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04217577's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI